Drug Detail:Lumateperone (Lumateperone [ loo-ma-te-per-one ])
Drug Class: Atypical antipsychotics
Lumateperone Levels and Effects while Breastfeeding
Summary of Use during Lactation
No information is available on the clinical use of lumateperone during breastfeeding. Because lumateperone is 97.5% bound to plasma proteins, the amount in milk is likely to be low. However, the manufacturer recommends that breastfeeding be discontinued during lumateperone therapy. Until more safety data become available, an alternate drug may be preferred.
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Alternate Drugs to Consider
(Antipsychotic) Haloperidol, Olanzapine, Risperidone, Quetiapine (Bipolar Disorder) Divalproex, Lithium, Olanzapine, Quetiapine, Risperidone, Valproic Acid
Substance Identification
Substance Name
Lumateperone
CAS Registry Number
313368-91-1
Drug Class
Breast Feeding
Lactation
Milk, Human
Antipsychotic Agents
-
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- Drug Levels and Effects
- Substance Identification